Objectives: The study aimed to investigate the association of Crohn's disease (CD) with transcobalamin II (TCN2) polymorphisms and serum homocysteine, folate, and vitamin B12 levels. Methods:TCN2 (rs1801198, rs9606756) were genotyped by iMLDR in 389 CD patients and 746 controls. Furthermore, 102 CD patients and 153 controls were randomly selected for examination of serum homocysteine, folate, and vitamin B12 levels by enzymatic cycling assay and chemiluminescence immunoassay, respectively. Results: Mutant allele (G) and genotype (AG + GG) of (rs9606756) were higher in CD patients than in controls (both p < 0.05). So were they in ileocolonic CD patients and stricturing CD patients compared to controls (all p < 0.05). Mutant allele (G) and genotype (CG + GG) of (rs1801198) were more prevalent in stricturing CD patients than in controls (both p < 0.05). Compared to controls, average homocysteine level was enhanced in CD patients (p = 0.003), whereas average folate and vitamin B12 levels were reduced in CD patients (both p < 0.001). The prevalence of hyperhomocysteinemia, folate deficiency, and vitamin B12 deficiency was higher in CD patients than in controls (all p < 0.01). Both folate deficiency and vitamin B12 deficiency were independently related to risk of CD (both p < 0.01). Conclusion:TCN2 (rs1801198, rs9606756) polymorphisms as well as folate deficiency and vitamin B12 deficiency are correlated with CD.

Keywords:
Crohn’s disease, Transcobalamin, Polymorphism, Homocysteine, Folate, Vitamin B12
1.
Lee YH, Song GG: Pathway analysis of a genome-wide association study of ileal Crohn's disease. DNA Cell Biol 2012;31:1549-1554.
2.
Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D'Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panés J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D'Amato M, Weersma RK, Kugathasan S, Griffiths AM, Mansfield JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M: Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Gene 2010;42:1118-1125.
3.
Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, Chan FK, Sung JJ: Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis 2012;18:1164-1176.
4.
Lai WK, Kan MY: Homocysteine-induced endothelial dysfunction. Ann Nutr Metab 2015;67:1-12.
5.
Munjal C, Tyagi N, Lominadze D, Tyagi SC: Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. J Cell Biochem 2012;113:1159-1169.
6.
Munjal C, Givvimani S, Qipshidze N, Tyagi N, Falcone JC, Tyagi SC: Mesenteric vascular remodeling in hyperhomocysteinemia. Mol Cell Biochem 2011;348:99-108.
7.
Dawson H, Collins G, Pyle R, Deep-Dixit V, Taub DD: The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function. Mech Ageing Dev 2004;125:107-110.
8.
Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A: Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005;100:886-895.
9.
Casella G, Antonelli E, Di Bella C, Di Marco E, Piatti M, Villanacci V, Bologna S, Baldini V, Bassotti G: Hyperhomocysteinemia in patients with Crohn's disease. Tech Coloproctol 2013;17:497-500.
10.
Jiang Y, Zhao J, Jiang T, Ge L, Zhou F, Chen Z, Lei Y, Huang S, Xia B: Genetic polymorphism of methylenetetrahydrofolate reductase G1793A, hyperhomocysteinemia, and folate deficiency correlate with ulcerative colitis in central China. J Gastroenterol Hepatol 2010;25:1157-1161.
11.
Liu AY, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM: Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res 2013;57:721-734.
12.
Martinelli M, Scapoli L, Mattei G, Ugolini G, Montroni I, Zattoni D, Rosati G, Solmi R: A candidate gene study of one-carbon metabolism pathway genes and colorectal cancer risk. Br J Nutr 2013;109:984-989.
13.
Kim HS, Lee BE, Jeon YJ, Rah H, Lee WS, Shin JE, Choi DH, Kim NK: Transcobalamin II (TCN2 67A>G and TCN2 776C>G) and transcobalamin II receptor (TCblR 1104C>T) polymorphisms in Korean patients with idiopathic recurrent spontaneous abortion. Am J Reprod Immunol 2014;72:337-346.
14.
Mills JL, Carter TC, Kay DM, Browne ML, Brody LC, Liu A, Romitti PA, Caggana M, Druschel CM: Folate and vitamin B12-related genes and risk for omphalocele. Hum Genet 2012;131:739-746.
15.
Zampieri BL, Biselli JM, Goloni-Bertollo EM, Vannucchi H, Carvalho VM, Cordeiro JA, Pavarino EC: Maternal risk for Down syndrome is modulated by genes involved in folate metabolism. Dis Markers 2012;32:73-81.
16.
Peyrin-Biroulet L, Guéant-Rodriguez RM, Chen M, Bronowicki JP, Bigard MA, Guéant JL: Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease. Am J Gastroenterol 2008;103:399-406.
17.
Chen M, Peyrin-Biroulet L, Xia B, Guéant-Rodriguez RM, Bronowicki JP, Bigard MA, Guéant JL: Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. BMC Med Genet 2008;9:78.
18.
Satsangi J, Silverberg MS, Vermeire S, Colombel JF: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-753.
19.
Peyrin-Biroulet L, Rodriguez-Guéant RM, Chamaillard M, Desreumaux P, Xia B, Bronowicki JP, Bigard MA, Guéant JL: Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol 2007;102:1108-1115.
20.
De Benoist B: Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food Nutr Bull 2008;29(2 suppl):S238-S244.
21.
Afman LA, Lievers KJ, Van Der Put NM, Trijbels FJ, Blom HJ: Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 2002;10:433-438.
22.
Stanisławska-Sachadyn A, Woodside JV, Sayers CM, Yarnell JW, Young IS, Evans AE, Mitchell LE, Whitehead AS: The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B12 status. Eur J Clin Nutr 2010;64:1338-1343.
23.
Silla Y, Chandamouli B, Maiti S, Sengupta S: A single nucleotide polymorphism in transcobalamin II (I5V) induces structural changes in the protein as revealed by molecular modeling studies. Biochemistry 2011;50:1396-1402.
24.
Riedel BM, Molloy AM, Meyer K, Fredriksen A, Ulvik A, Schneede J, Nexø E, Hoff G, Ueland PM: Transcobalamin polymorphism 67A->G, but not 776C->G, affects serum holotranscobalamin in a cohort of healthy middle-aged men and women. J Nutr 2011;141:1784-1790.
25.
Ding H, Gan HZ, Fan WJ, Cao LY, Xu JM, Mei Q: Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci 2015;60:375-381.
26.
Kallel L, Feki M, Sekri W, Segheir L, Fekih M, Boubaker J, Kaabachi N, Filali A: Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn's disease. J Crohns Colitis 2011;5:110-114.
27.
Vagianos K, Bernstein CN: Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study. Inflamm Bowel Dis 2012;18:718-724.
28.
Erzin Y, Uzun H, Celik AF, Aydin S, Dirican A, Uzunismail H: Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications. J Clin Gastroenterol 2008;42:481-486.
29.
Chiarello PG, Penaforte FR, Japur CC, Souza CD, Vannucchi H, Troncon LE: Increased folate intake with no changes in serum homocysteine and decreased levels of C-reactive protein in patients with inflammatory bowel diseases. Dig Dis Sci 2009;54:627-633.
30.
Ullegaddi R, Powers HJ, Gariballa SE: B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin Sci 2004;107:477-484.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.